SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 14, 2000 CVS CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-1011 05-0494040 (State of incorporation) (Commission (IRS Employer File no.) Identification No.) One CVS Drive Woonsocket, Rhode Island 02895 (Address of principal executive offices including zip code) Registrant's telephone number, including area code: (401) 765-1500 NOT APPLICABLE (Former name or former address, if changed since last report) Item 5. Other Events. CVS Corporation, a Delaware corporation (the "Corporation") has filed its proxy statement on March 10, 2000 which, as result of the inclusion of the treasury shares in the calculation made by the transfer agent, indicated that approximately 402.9 million shares of the Corporation's common stock were outstanding as of the record date. The correct number for the shares outstanding as of the record date is approximately 391.8 million. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CVS CORPORATION Date: March 14, 2000 By: /s/ David B. Rickard ------------------------------ Name: David B. Rickard Title: Executive Vice President and Chief Financial Officer